Anti-colitic effects of kanjangs (fermented soy sauce and sesame sauce) in dextran sulfate sodium-induced colitis in mice

Journal of Medicinal Food

Volumn 17, Issue 9, 2014, Pages 1027-1035

  Song, Jia Le ^a   Choi, Jung Ho ^b   Seo, Jae Hoon ^b   Lim, Yaung Iee ^c   Park, Kun Young ^a  

^a Pusan National University   (South Korea)

^b Daesang RandD   (South Korea)

^c Sungshin Women's University   (South Korea)

Author keywords

colitis; dextran sulfate sodium; fermented sesame sauce; fermented soy sauce; kanjang; pro inflammatory cytokines

Indexed keywords

AGENTS USED IN INFLAMMATORY BOWEL DISEASE; CYCLOOXYGENASE 2; DEXTRAN SULFATE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 17; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; CYTOKINE; PLANT MEDICINAL PRODUCT;

ACID HYDROLYZED SOY SAUCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD LEVEL; BODY WEIGHT; CHEMICAL COMPOSITION; COLON; COLON MUCOSA; COMPARATIVE STUDY; CONTROLLED STUDY; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; DIGESTIVE TRACT PARAMETERS; EDEMA; ENZYME INHIBITION; FEMALE; FERMENTATION; FERMENTED PRODUCT; FERMENTED SESAME SAUCE; FERMENTED SOY SAUCE; GENE EXPRESSION; HISTOLOGY; MOUSE; MUCOSAL DISEASE; NONHUMAN; SESAME; STOMACH PROTECTION; ULCERATIVE COLITIS; WEIGHT REDUCTION; ANIMAL; BLOOD; C57BL MOUSE; CHEMICALLY INDUCED; DIET THERAPY; DRUG EFFECTS; GENETICS; INTESTINE MUCOSA; METABOLISM; PATHOLOGY; PHYTOTHERAPY; SESAMUM; SOY FOOD;

ANIMALS; ANTI-INFLAMMATORY AGENTS; COLITIS, ULCERATIVE; COLON; CYCLOOXYGENASE 2; CYTOKINES; DEXTRAN SULFATE; EDEMA; FEMALE; FERMENTATION; INTESTINAL MUCOSA; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE TYPE II; PHYTOTHERAPY; PLANT PREPARATIONS; SESAMUM; SOY FOODS; WEIGHT LOSS;

EID: 84906981117     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2013.3119     Document Type: Article

References (59)

1. Liu K: Soybean as Functional Foods and Ingredients. AOAC Press, Champaign, IL, 2004, p. 269.
2. Song JL: Anticancer effects of fermneted sesame sauce. Dcotoral Thesis, Pusan National University, Busan, Korea, 2012.
3. Ham SS, Kim SH, Yoo SJ, et al.: Biological activities of soybean sauce (Kanjang) supplemented with deep sea water and sea tangle. Korean J Food Preserv 2008;15:274-279.
4. Yoon KD, Kwon DJ, Hong SS, Kim SI, Chung KS: Inhibitory effect of soybean and fermented soybean products on the chemically induced mutagenesis. Korean J Appl Microbiol Bio-technol 1996;24:525-528.
5. Aoshima H, Ooshima S: Anti-hydrogen peroxide activity of fish and soy sauce. Food Chem 2009;112:339-343.
6. Wang H, Jenner AM, Lee CY, et al.: The identification of anti-oxidants in dark soy sauce. Free Radic Res 2007;41:479-488.
7. Song JL, Choi JH, Seo JH, Kil JH, Park KY: Antioxidative effects of fermented sesame sauce against hydrogen peroxide-induced oxidative damage in LLC-PK1 porcine renal tubule cells. Nutr Res Pract 2014;8:138-145.
8. Benjamin H, Storkson J, Nagahara A, Pariza MW: Inhibition of benzo (a) pyrene-induced mouse forestomach neoplasia by dietary soy sauce. Cancer Res 1991;51:2940-2942.
9. Nagahara A, Benjamin H, Storkson J, et al.: Inhibition of benzo [a] pyrene-induced mouse forestomach neoplasia by a principal flavor component of Japanese-style fermented soy sauce. Cancer Res 1992;52:1754-1756.
10. Ito A, Watanabe H, Basaran N: Effects of soy products in reducing risk of spontaneous and neutron-induced liver-tumors in mice. Int J Oncol 1993;2:773-776.
11. Steidler L, Hans W, Schotte L, et al.: Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 2000; 289:1352-1355.
12. Yang SK, Yun S, Kim JH, et al.: Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: A KASID study. Inflamm Bowel Dis 2008;14:542-549.
13. Abraham C, Cho JH: Inflammatory Bowel Disease. N Engl J Med 2009;361:2066-2078.
14. Baumgart DC, Carding SR: Inflammatory bowel disease: cause and immunobiology. Lancet 2007;369:1627-1640.
15. Mudter J, Neurath MF: IL-6 signaling in inflammatory bowel disease: Pathophysiological role and clinical relevance. Inflamm Bowel Dis 2007;13:1016-1023.
16. Rovedatti L, Kudo T, Biancheri P, et al.: Differential regulation of interleukin 17 and interferon c production in inflammatory bowel disease. Gut 2009;58:1629-1636.
17. Okayasu I, Hatakeyama S, Yamada M, et al.: A novel method in the induction of reliable experimental acute and chronic ulcera-tive colitis in mice. Gastroenterology 1990;98:694-702.
18. Fischer RB, Peters DG: Basic Theory and Practice of Quantitative Chemical Analysis, 3rd edition. WB Saunders, Philadelphia, PA, USA 1968, pp. 375-396.
19. Miller GL: Use of dinitrosalicylic acid reagent for determination of reducing sugar. Anal Chem 1959;31:426-428.
20. Beddows C, Ismail M, Steinkraus K: The use of bromelain in the hydrolysis of mackerel and the investigation of fermented fish aroma. Int J Food Sci Technol 1976;11:379-388.
21. Taga MS, Miller E, Pratt DE: Chia seeds as a source of natural lipid antioxidants. J Am Oil Chem Soc 1984;61:928-931.
22. Fiocchi C: Inflammatory bowel disease: etiology and pathogen-esis. Gastroenterology 1998;115:182-205.
23. Hendrickson BA, Gokhale R, Cho JH: Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev 2002;15:79-94.
24. Kudou S, Fleury Y, Welti D, et al.: Malonyl isoflavone glyco-sides in soybean seeds (Glycine max Merrill). Agric Biol Chem 1991;55:2227-2233.
25. Wang H, Murphy PA: Isoflavone composition of American and Japanese soybeans in Iowa: effects of variety, crop year, and location. J Agric Food Chem 1994;42:1674-1677.
26. Chang TS, Ding HY, Tai SS, Wu CY: Metabolism of the soy isoflavones daidzein and genistein by fungi used in the preparation of various fermented soybean foods. Biosci Biotechnol Biochem 2007;71:1330-1333.
27. Lee IH, Chou CC: Distribution profiles of isoflavone isomers in black bean kojis prepared with various filamentous fungi. J Agric Food Chem 2006;54:1309-1314.
28. Choi YB, Sohn HS: Isoflavone content in Korean fermented and unfermented soybean foods. Korean J Food Sci Technol 1998;30: 745-750.
29. Kang CS, Lee YS, Kim JS, Hahn YH: High performance liquid chromatographic analysis of isoflavones in soybean foods. Korean J Food Sci Technol 2000;32:25-30.
30. Katsuzaki H, Kawakishi S, Osawa T: Sesaminol glucosides in sesame seeds. Phytochemistry 1994;35:773-776.
31. Moazzami AA, Andersson RE, Kamal-Eldin A: HPLC analysis of sesaminol glucosides in sesame seeds. J Agric Food Chem 2006;54:633-638.
32. Miyake Y, Fukumoto S, Okada M, et al.: Antioxidative catechol lignans converted from sesamin and sesaminol triglucoside by culturing with Aspergillus. J Agric Food Chem 2005;53:22-27.
33. Collier P, Cromie DDO, Davies A: Mechanism of formation of chloropropanols present in protein hydrolysates. J Am Oil Chem Soc 1991;68:785-790.
34. Crews C, Le Brun G, Hough P, Harvey D, Brereton P: Chlorinated propanols and levulinic acid in soy sauces. Czech J Food Sci 2000;18:276-277.
35. Lynch BS, Bryant DW, Hook GJ, Nestmann ER, Munro IC: Carcinogenicity of monochloro-1, 2-propanediol (a-chlorohy-drin, 3-MCPD). Int J Toxicol 1998;17:47-76.
36. BIBRA Working Group: 1, 3-dichloro-2-propanol. In Toxicity profile. TNO-BIBRA International Ltd., Carshalton, Surrey, UK. 1999.
37. Habermeyer M, Guth S, Eisenbrand G: Identification of gaps in knowledge concerning toxicology of 3-MCPD and glycidol esters. Eur J Lipid Sci Technol 2011;113:314-318.
38. Shao LN: Studies on physicochemical changes and cancer preventive effects of fermented soy sauce during ripening period. Master Thesis, Pusan National University, Busan, Korea, 2009.
39. Jung KO, Park SY, Park KY: Longer aging time increases the anticancer and antimetastatic properties of doenjang. Nutrition 2006;22:539-545.
40. Tuyns AJ: Salt and gastrointestinal cancer. Nutr Cancer 1988;11: 229-232.
41. Kim SH, Park KY, Suh MJ: Comutagenic effect of sodium chloride in the Salmonella/mammalian microsome assay. Food Biotechnol 1995;4:264-267.
42. Sandle G, Higgs N, Crowe P, et al.: Cellular basis for defective electrolyte transport in inflamed human colon. Gastroenterology 1990;99:97-105.
43. Sandle G, Hayslett J, Binder H: Effect of glucocorticoids on rectal transport in normal subjects and patients with ulcerative colitis. Gut 1986;27:309-316.
44. Irving PM, Shanahan F, Rampton DS: Drug interactions in inflammatory bowel disease. Am J Gastroenterol 2008;103:207-219.
45. Morimoto M, Watanabe T, Yamori M, Takebe M, Wakatsuki Y: Isoflavones regulate innate immunity and inhibit experimental colitis. J Gastroenterol Hepatol 2009;24:1123-1129.
46. Sakai T, Furoku S, Nakamoto M, et al.: Soy isoflavone equol perpetuates dextran sulfate sodium-induced acute colitis in mice. Biosci Biotechnol Biochem 2011;75:593-595.
47. Seibel J, Molzberger AF, Hertrampf T, Laudenbach-Leschowski U, Diel P: Oral treatment with genistein reduces the expression of molecular and biochemical markers of inflammation in a rat model of chronic TNBS-induced colitis. Eur J Nutr 2009;48: 213-220.
48. Jeng KCG, Hou RCW: Sesamin and sesamolin: natures therapeutic lignans. Curr Enzyme Inhib 2005;1:11-20.
49. Kao TH, Wu WM, Hung CF, Wu WB, Chen BH: Anti-inflammatory effects of isoflavone powder produced from soybean cake. J Agric Food Chem 2007;55:11068-11079.
50. Jeng KCG, Hou RCW, Wang JC, Ping LI: Sesamin inhibits li-popolysaccharide-induced cytokine production by suppression of p38 mitogen-activated protein kinase and nuclear factor-jB. Immunol Lett 2005;97:101-106.
51. Utsunomiya T, Chavali SR, Zhong WW, Forse RA: Effects of sesamin-supplemented dietary fat emulsions on the ex vivo production of lipopolysaccharide-induced prostanoids and tumor necrosis factor a in rats. Am J Clin Nutr 2000;72:804-808.
52. Kankuri E, Asmawi MZ, Korpela R, Vapaatalo H, Moilanen E: Induction of iNOS in a rat model of acute colitis. Inflammation 1999;23:141-152.
53. Sakamoto C: Roles of COX-1 and COX-2 in gastrointestinal pathophysiology. J Gastroenterol 1998;33:618-624.
54. Hämäläinen M, Nieminen R, Vuorela P, Heinonen M, Moilanen E: Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-jB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-jB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediat Inflamm 2007;2007:45673.
55. Kim AR, Cho JY, Zou Y, Choi JS, Chung HY: Flavonoids differentially modulate nitric oxide production pathways in lipo-polysaccharide-activated RAW264.7 cells. Arch Pharm Res 2005;28:297-304.
56. Liang YC, Huang YT, Tsai SH, et al.: Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis 1999;20:1945-1952.
57. Mutoh M, Takahashi M, Fukuda K, et al.: Suppression of cy-clooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells by chemopreventive agents with a resorcin-type structure. Carcinogenesis 2000;21:959-963.
58. Harikumar KB, Sung B, Tharakan ST, et al.: Sesamin manifests chemopreventive effects through the suppression of NF-jB-regulated cell survival, proliferation, invasion, and angiogenic gene products. Mol Cancer Res 2010;8:751-761.
59. Hsieh PF, Hou CW, Yao PW, et al.: Sesamin ameliorates oxi-dative stress and mortality in kainic acid-induced status epi-lepticus by inhibition of MAPK and COX-2 activation. J Neuroinflammation 2011;8:1-10.